ARTICLE | Company News
Transgene, Virax deal
March 19, 2007 7:00 AM UTC
Transgene received U.S. and Canadian rights to use VHL's Co-X-Gene immunotherapy technology for Transgene's TG4010 and TG4001 therapeutic DNA vaccines. TG4010, which expresses MUC-1 ( CD227) and in...